A Study to Learn About a New Medicine Called ARV-471 (PF-07850327) in People Who Have Advanced Metastatic Breast Cancer.
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: ARV-471|DRUG: Fulvestrant
Sponsor: Pfizer
Collaborators: Arvinas Estrogen Receptor, Inc.